8月5日，Hinge Health盘中上涨5.09%，报82.41美元/股，成交额2458.87万美元。消息面上，公司盘前公布Q2财报，营收2.13亿美元超出市场预期的2.01亿美元，同比增长53%；调整后每股收益0.59美元基本符合一致预期。更为关键的是，公司将全年营收指引大幅上调至8.56亿至8.60亿美元，远超分析师此前预期的8.22亿美元，Q3营收指引2.23亿至2.25亿美元同样显著高于市场预期的2.12亿美元。
此外，摩根士丹利当日将公司目标价由108美元上调至117美元，维持"增持"评级，进一步提振市场情绪。尽管盘后曾因EPS同比下滑短暂回调，但强劲的收入增长动能及持续上修的业绩指引令多头迅速回补。Hinge Health是一家AI驱动的数字肌肉骨骼护理平台，通过可穿戴设备和专业临床团队提供从急性损伤到术后康复的全流程服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.